245620 — Eone Diagnomics Genome Center Co Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Eone Diagnomics Genome Center Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -8,211 | -8,172 | -20,229 | -29,789 | -33,027 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1,109 | 6,260 | 7,022 | 21,013 | 25,164 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4,594 | -7,686 | 5,886 | -8,292 | -12,431 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -9,363 | -5,497 | -1,730 | -10,892 | -14,025 |
Capital Expenditures | -8,613 | -5,747 | -13,786 | -39,409 | -6,083 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -7,334 | -8,904 | -45,225 | 2,961 | 10,093 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -15,947 | -14,652 | -59,011 | -36,448 | 4,011 |
Financing Cash Flow Items | — | 10 | -156 | -2,378 | -12.1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 25,271 | 63,118 | 27,467 | 24,081 | 14,616 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7.16 | 42,699 | -33,067 | -22,851 | 4,749 |